Literature DB >> 7640584

Low serum total cholesterol concentrations and mortality in middle aged British men.

G Wannamethee1, A G Shaper, P H Whincup, M Walker.   

Abstract

OBJECTIVE: To examine the relation between low serum total cholesterol concentrations and causes of mortality.
DESIGN: Cohort study of men followed up for an average of 14.8 years (range 13.5-16.0 years).
SETTING: One general practice in each of 24 British towns.
SUBJECTS: 7735 men aged 40-59 at screening selected at random from the 24 general practices. MAIN OUTCOME MEASURES: Deaths from all causes, cardiovascular causes, cancer, and non-cardiovascular, non-cancer causes.
RESULTS: During the mean follow up period of 14.8 years there were 1257 deaths from all causes, 640 cardiovascular deaths, 433 cancer deaths, and 184 deaths from other causes. Low serum cholesterol concentrations (< 4.8 mmol/l), present in 5% (n = 410) of the men, were associated with the highest mortality from all causes, largely due to a significant increase in cancer deaths (age adjusted relative risk 1.6 (95% confidence interval 1.1 to 2.3); < 4.8 v 4.8-5.9 mmol/l) and in other non-cardiovascular deaths (age adjusted relative risk 1.9 (1.1 to 3.1)). Low serum cholesterol concentration was associated with an increased prevalence of several diseases and indicators of ill health and with lifestyle characteristics such as smoking and heavy drinking. After adjustment for these factors in the multivariate analysis the increased risk for cancer was attenuated (relative risk 1.4 (0.9 to 2.0) and the inverse association with other non-cardiovascular, non-cancer causes was no longer significant (relative risk 1.5 (0.9 to 2.6); < 4.8 v 4.8-5.9 mmol/l). The excess risks of cancer and of other non-cardiovascular deaths were most pronounced in the first five years and became attenuated and non-significant with longer follow up. By contrast, the positive association between serum total cholesterol concentration and cardiovascular mortality was seen even after more than 10 years of follow up.
CONCLUSION: The association between comparatively low serum total cholesterol concentrations and excess mortality seemed to be due to preclinical cancer and other non-cardiovascular diseases. This suggests that public health programmes encouraging lower average concentrations of serum total cholesterol are unlikely to be associated with increased cancer or other non-cardiovascular mortality.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7640584      PMCID: PMC2550486          DOI: 10.1136/bmj.311.7002.409

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  30 in total

1.  Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial.

Authors:  R W Sherwin; D N Wentworth; J A Cutler; S B Hulley; L H Kuller; J Stamler
Journal:  JAMA       Date:  1987-02-20       Impact factor: 56.272

2.  Lipids, lipoproteins, and apoproteins in serum during infection.

Authors:  C Alvarez; A Ramos
Journal:  Clin Chem       Date:  1986-01       Impact factor: 8.327

3.  Follow-up of subjects in prospective studies based in general practice.

Authors:  M Walker; A G Shaper
Journal:  J R Coll Gen Pract       Date:  1984-07

4.  An apparent inverse relationship between serum cholesterol and cancer mortality in Puerto Rico.

Authors:  M R Garcia-Palmieri; P D Sorlie; R Costas; R J Havlik
Journal:  Am J Epidemiol       Date:  1981-07       Impact factor: 4.897

5.  Serum cholesterol and mortality in a Japanese-American population: the Honolulu Heart program.

Authors:  A Kagan; D L McGee; K Yano; G G Rhoads; A Nomura
Journal:  Am J Epidemiol       Date:  1981-07       Impact factor: 4.897

6.  Serum cholesterol and the incidence of cancer in a large cohort.

Authors:  R A Hiatt; B H Fireman
Journal:  J Chronic Dis       Date:  1986

7.  Serum cholesterol and cancer in the NHANES I epidemiologic followup study. National Health and Nutrition Examination Survey.

Authors:  A Schatzkin; R N Hoover; P R Taylor; R G Ziegler; C L Carter; D B Larson; L M Licitra
Journal:  Lancet       Date:  1987-08-08       Impact factor: 79.321

8.  British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns.

Authors:  A G Shaper; S J Pocock; M Walker; N M Cohen; C J Wale; A G Thomson
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-18

9.  Blood lipids in middle-aged British men.

Authors:  D S Thelle; A G Shaper; T P Whitehead; D G Bullock; D Ashby; I Patel
Journal:  Br Heart J       Date:  1983-03

10.  Are low cholesterol values associated with excess mortality?

Authors:  C E Salmond; R Beaglehole; I A Prior
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-09
View more
  11 in total

Review 1.  Cancer and cholesterol: understanding the V-shaped association in patients with diabetes.

Authors:  Eric L Ding; Frank B Hu
Journal:  CMAJ       Date:  2008-08-26       Impact factor: 8.262

2.  Diabetes: Low HbA1c levels and mortality in type 2 diabetes mellitus.

Authors:  Shamsa Ali; Vivian A Fonseca
Journal:  Nat Rev Endocrinol       Date:  2010-07       Impact factor: 43.330

3.  Causal link between low cholesterol and cancer is unlikely.

Authors:  A C Sönnichsen; C Otto; W O Richter; P Schwandt
Journal:  BMJ       Date:  1995-11-25

4.  The importance of considering alternative or combination strategies for lowering LDL-C.

Authors:  Kwang Kon Koh; Michael J Quon
Journal:  Int J Cardiol       Date:  2009-04-03       Impact factor: 4.164

5.  Is the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the Norwegian HUNT 2 study.

Authors:  Halfdan Petursson; Johann A Sigurdsson; Calle Bengtsson; Tom I L Nilsen; Linn Getz
Journal:  J Eval Clin Pract       Date:  2011-09-25       Impact factor: 2.431

6.  Which biomarkers are predictive specifically for cardiovascular or for non-cardiovascular mortality in men? Evidence from the Caerphilly Prospective Study (CaPS).

Authors:  Christopher C Patterson; Stefan Blankenberg; Yoav Ben-Shlomo; Luke Heslop; Antony Bayer; Gordon Lowe; Tanja Zeller; John Gallacher; Ian Young; John Yarnell
Journal:  Int J Cardiol       Date:  2015-08-05       Impact factor: 4.164

7.  Serum total cholesterol concentration and 10-year mortality in an 85-year-old population.

Authors:  Yutaka Takata; Toshihiro Ansai; Inho Soh; Shuji Awano; Ikuo Nakamichi; Sumio Akifusa; Kenichi Goto; Akihiro Yoshida; Hiroki Fujii; Ritsuko Fujisawa; Kazuo Sonoki
Journal:  Clin Interv Aging       Date:  2014-02-13       Impact factor: 4.458

8.  Impact of coexisting pulmonary diseases on survival of patients with lung adenocarcinoma: a STROBE-compliant article.

Authors:  Zhi-Hong Jian; Jing-Yang Huang; Pei-Chieh Ko; Shiou-Rung Jan; Oswald Ndi Nfor; Chia-Chi Lung; Wen-Yuan Ku; Chien-Chang Ho; Hui-Hsien Pan; Yung-Po Liaw
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

9.  Association of serum levels of lipid and its novel constituents with the different stages of esophageal carcinoma.

Authors:  Yutao Diao; Hao Li; Huiqing Li; Yingzhi Zhou; Qing Ma; Yan Wang; Dong Li
Journal:  Lipids Health Dis       Date:  2009-10-29       Impact factor: 3.876

10.  Lower serum levels of total cholesterol are associated with higher urinary levels of 8-hydroxydeoxyguanosine.

Authors:  Hiroyuki Kikuchi; Akiko Nanri; Ai Hori; Masao Sato; Kazuaki Kawai; Hiroshi Kasai; Tetsuya Mizoue
Journal:  Nutr Metab (Lond)       Date:  2013-10-02       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.